Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers

$14.96M USD

Funder	FOOD AND DRUG ADMINISTRATION
Recipient Organization	Sloan-Kettering Inst Can Research
Country	United States
Start Date	Sep 05, 2024
End Date	Aug 31, 2027
Duration	1,090 days
Number of Grantees	2
Roles	Principal Investigator; Co-Investigator
Data Source	NIH (US)
Grant ID	`11067224`

Grant Description

Project Summary Despite advances in treatment, sarcomas like rhabdoid tumors and desmoplastic small round cell tumors (DSRCT) remain challenging, with frequent therapy resistance and fatal outcomes. The rarity of these cancers (